Companies

UTAH MEDICAL PRODUCTS INC

UTMD · CIK 0000706698 · operating

$66.39-0.33%Last updated Mar 2, 8:29 PM

Key Statistics

Valuation

Market Cap$213.40M
P/E19.14
Fwd P/E
PEG
P/S5.54
P/B1.78
EV/EBITDA8.83
EV/Rev3.29

Profitability

Gross Margin58.13%
Op. Margin148.45%
Net Margin31.69%
ROE2.47%
ROA2.37%
FCF Margin159.45%

Financial Health

Current Ratio25.64
Debt/Equity0.04
Free Cash Flow$14.60M
Div. Yield1.86%

Growth & Other

Revenue Growth-25.75%
EPS Growth-27.12%
Beta0.35
52W High$68.71
52W Low$51.26

About UTAH MEDICAL PRODUCTS INC

Utah Medical Products designs and manufactures specialized medical devices for use in labor and delivery, women's health, neonatal care, and critical care monitoring. The company's product portfolio spans fetal monitoring accessories, vacuum-assisted delivery systems, blood pressure monitoring systems, and various catheterization and sampling devices. Key branded products include the DELTRAN blood pressure transducers, DISPOSA-HOOD infant respiratory hoods, the LETZ system for cervical tissue removal, Filshie Clip contraception devices, and the LIBERTY urinary incontinence treatment system. The company also offers electrosurgical devices, laparoscopic instruments and trocars, endoscopic irrigation devices, and pressure monitoring components.

The company serves neonatal intensive care units, labor and delivery departments, women's health centers within hospitals, and outpatient clinics and physician offices. Its customer base is primarily domestic, though the company operates on a worldwide basis. Utah Medical Products was incorporated in 1978 and maintains headquarters in Midvale, Utah. The organization operates with a focused product strategy concentrated on obstetrics, gynecology, neonatal care, and related critical care monitoring applications rather than pursuing broader diversification within medical devices.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$0.86$3.96-27.1%
2023$1.18$4.58-5.6%
2022$1.25$4.53+10.6%
2021$1.13$4.05+20.2%
2020$0.94$2.95-19.7%
2019$1.17$3.96+28.6%
2018$0.91$4.97-60.1%
2017$2.28$2.29-29.2%
2016$3.22$3.23+2.5%
2015$3.14$3.16+4.0%
2014$3.02$3.04+0.0%
2013$3.02$3.06+10.2%
2012$2.74$2.77+35.0%
2011$2.03$2.04

Annual Reports (10-K) · 30 filings

Report DateFiledAccession Number
2024-12-312025-03-260001096906-25-000308SEC ↗
2023-12-312024-03-260001811884-24-000009SEC ↗
2022-12-312023-03-270001811884-23-000004SEC ↗
2021-12-312022-03-250001811884-22-000004SEC ↗
2020-12-312021-03-260001811884-21-000004SEC ↗
2019-12-312020-03-160001096906-20-000111SEC ↗
2018-12-312019-03-140001096906-19-000100SEC ↗
2017-12-312018-03-060001096906-18-000127SEC ↗
2016-12-312017-03-080001096906-17-000145SEC ↗
2015-12-312016-03-100001096906-16-001451SEC ↗
2014-12-312015-03-120001096906-15-000240SEC ↗
2013-12-312014-03-120001096906-14-000293SEC ↗
2012-12-312013-03-070001096906-13-000305SEC ↗
2011-12-312012-03-120001096906-12-000512SEC ↗
2010-12-312011-03-030001096906-11-000415SEC ↗
2009-12-312010-03-090001096906-10-000273SEC ↗
2008-12-312009-03-060001096906-09-000189SEC ↗
2007-12-312008-03-070001096906-08-000399SEC ↗
2006-12-312007-03-160001096906-07-000376SEC ↗
2005-12-312006-03-160001096906-06-000158SEC ↗
2004-12-312005-03-160001096906-05-000089SEC ↗
2003-12-312004-03-150001096906-04-000128SEC ↗
2002-12-312003-03-270001096906-03-000130SEC ↗
2001-12-312002-04-010001096906-02-000253SEC ↗
2000-12-312001-03-290001096906-01-000109SEC ↗
1999-12-312000-03-300001096906-00-000050SEC ↗
1998-12-311999-03-300000914233-99-000021SEC ↗
1997-12-311998-03-310000914233-98-000022SEC ↗
1996-12-311997-03-310000914233-97-000042SEC ↗
1995-12-311996-04-010000914233-96-000019SEC ↗